Successful treatment with anti-CD20 monoclonal antibody (rituximab) of life-threatening refractory systemic lupus erythematosus with renal and central nervous system involvement

被引：55
|
作者：
Saito, K [1 ]
Nawata, M [1 ]
Nakayamada, S [1 ]
Tokunaga, M [1 ]
Tsukada, J [1 ]
Tanaka, Y [1 ]
机构：
[1] Univ Occupat & Environm Hlth, Dept Internal Med 1, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan
来源：
LUPUS | 2003年 / 12卷 / 10期
关键词：
D O I：
10.1191/0961203303lu450xx
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：798 / 800
页数：3
相关论文
共 50 条
  • [1] Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus
    Perrotta, S
    Locatelli, F
    La Manna, A
    Cennamo, L
    De Stefano, P
    Nobili, B
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (02) : 465 - 467
  • [2] Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system
    Tokunaga, Mikiko
    Saito, Kazuyoshi
    Kawabata, Daisuke
    Imura, Yoshitaka
    Fujii, Takao
    Nakayamada, Shingo
    Tsujimura, Shizuyo
    Nawata, Masao
    Iwata, Shigeru
    Azuma, Taeko
    Mimori, Tsuneyo
    Tanaka, Yoshiya
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (04) : 470 - 475
  • [3] Successful use of anti-CD20 monoclonal antibody (Rituximab) for life-threatening refractory childhood immune thrombocytopenic purpura
    Bengston, KL
    Skinner, MA
    Ware, RE
    PEDIATRIC RESEARCH, 2002, 51 (04) : 241A - 241A
  • [4] Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.
    Tanaka, Y
    Tokunaga, M
    Kawabata, D
    Imura, Y
    Fujii, T
    Nawata, M
    Tsujimura, S
    Nakayamada, S
    Mimoro, T
    Saito, K
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S191 - S191
  • [5] Anti-CD20 monoclonal antibody (rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus
    ten Cate, R
    Smiers, FJ
    Bredius, RGM
    Lankester, AC
    van Suijlekom-Smit, LWA
    Huizinga, TW
    Egeler, RM
    RHEUMATOLOGY, 2004, 43 (02) : 244 - 245
  • [6] Rituximab (anti-CD20 monoclonal antibody) for refractory systemic lupus erythematosus.: Report of one case
    Sabugo, F
    Llanos, C
    Soto, L
    Gutiérrez, J
    Cuchacovich, M
    REVISTA MEDICA DE CHILE, 2005, 133 (06) : 681 - 684
  • [7] Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus
    Fukushima, T.
    Dong, L.
    Sakai, T.
    Sawaki, T.
    Miki, M.
    Tanaka, M.
    Masaki, Y.
    Hirose, Y.
    Kuwana, M.
    Umehara, H.
    LUPUS, 2008, 17 (03) : 210 - 214
  • [8] Successful treatment of refractory immune thrombocytopenia with anti-CD20 antibody in a patient with systemic lupus erythematosus
    Lee, J-W
    Kim, H-A
    Sung, J-M
    Suh, C-H
    LUPUS, 2010, 19 (02) : 227 - 228
  • [9] Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus
    Iwata, S.
    Saito, K.
    Hirata, S.
    Ohkubo, N.
    Nakayamada, S.
    Nakano, K.
    Hanami, K.
    Kubo, S.
    Miyagawa, I.
    Yoshikawa, M.
    Miyazaki, Y.
    Yoshinari, H.
    Tanaka, Y.
    LUPUS, 2018, 27 (05) : 802 - 811
  • [10] Anti-CD20 monoclonal antibody (Rituximab) for life-threatening hemolytic-uremic syndrome
    Yassa, SK
    Blessios, G
    Marinides, G
    Venuto, RC
    CLINICAL TRANSPLANTATION, 2005, 19 (03) : 423 - 426
12345